British Journal of Clinical Pharmacology

Cover image for Vol. 79 Issue 1

Edited By: J.M. Ritter (Editor-in-Chief), A. Cohen (European Editor), Y.K. Loke (European Editor), A. Somogyi (Australasian Editor), D. Flockhart (American Editor), and A. Ferro (Reviews Editor)

Impact Factor: 3.688

ISI Journal Citation Reports © Ranking: 2013: 50/256 (Pharmacology & Pharmacy)

Online ISSN: 1365-2125

Associated Title(s): British Journal of Pharmacology

FREE ACCESS: Top cited BJCP papers in 2013 IF window

Top Ten Most Cited Articles of 2013

Below you will find a list of the top ten most cited papers in the British Journal of Clinical Pharmacology (in the 2013 Impact Factor window). These are free to access, so reading some of our most influential papers is just one click away.

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
Salvatore Salomone, Filippo Caraci, Gian Marco Leggio, Julia Fedotova and Filippo Drago

4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Ulf Diczfalusy, Hanna Nylén, Pontus Elander and Leif Bertilsson

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
Sunil M. Shah, Iain M. Carey, Christopher G. Owen, Tess Harris, Stephen DeWilde and Derek G. Cook

SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
Aili L. Lazaar, Lisa E. Sweeney, Alexander J. MacDonald, Neil E. Alexis, Chao Chen and Ruth Tal-Singer

A new taxonomy for describing and defining adherence to medications
Bernard Vrijens, Sabina De Geest, Dyfrig A. Hughes, Kardas Przemyslaw, Jenny Demonceau, Todd Ruppar, Fabienne Dobbels, Emily Fargher, Valerie Morrison, Pawel Lewek, Michal Matyjaszczyk, Comfort Mshelia, Wendy Clyne, Jeffrey K. Aronson, J. Urquhart and for the ABC Project Team

Resveratrol – pills to replace a healthy diet?
Veronique S. Chachay, Carl M. J. Kirkpatrick, Ingrid J. Hickman, Maree Ferguson, Johannes B. Prins and Jennifer H. Martin

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Kawser Akter, Emily A. Lanza, Stephen A. Martin, Natalie Myronyuk, Melanie Rua and Robert B. Raffa

Treatment of systemic lupus erythematosus with epratuzumab
Pawel Traczewski and Lidia Rudnicka

Anti-platelet therapy: phosphodiesterase inhibitors
Paolo Gresele, Stefania Momi and Emanuela Falcinelli

Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
Zhenhua Xu, Esther Bouman-Thio, Craig Comisar, Bart Frederick, Bart Van Hartingsveldt, Joseph C. Marini, Hugh M. Davis and Honghui Zhou